Iran announces production of local COVID-19 vaccine
Iran on Sunday announced the start of production of a local coronavirus vaccine as it entered Phase 3 of human trials, the semi-official Fars news agency reported.
Iran on Sunday announced the start of production of a local coronavirus vaccine as it entered Phase 3 of human trials, the semi-official Fars news agency reported.
According to a statement by Mohammad Mokhber, the head of Iran's scientific committee to combat COVID-19, one million doses of the local COV-Iran Barekat vaccine will be delivered to the Iranian Health Ministry within one month.
He said a further 3 to 3.5 million doses of the local vaccine will be produced by June, with production to reach 50 million doses by the end of September.
A second local Iranian vaccine, COV-Pars, entered the human trials phase on Feb. 28 on 133 volunteers, and a second phase of clinical trials will begin in early June with 500 volunteers.
As of Sunday, Iran’s tally of infections surged to nearly 2.38 million, including 69,120 deaths.
The Rocket and Artillery formations of the Azerbaijan Army conduct live-fire exercises in accordance with the combat training plan for 2021, the Ministry of Defense of Azerbaijan told Baku Tribune.
.jpg&h=67&w=67&zc=1&q=100)
LAST NEWS
Editor's note: Eugene Chausovsky is a senior analyst at the Newlines Institute. Chausovsky previously served as senior Eurasia analyst at the geopolitical analysis firm Stratfor for more than 10 years. His work focuses on political, economic, and security issues pertaining to Russia, Eurasia, and the Middle East.
